In few months, Denmark's best selling drug, Humira from Abbvie, has nearly disappeared from the Danish hospitals. New biosimilar drugs have stolen market shares at record speed, and Amgros expects to save approximately DKK 400 million (USD 61.18 million) in 2019.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.